D. E. BRUNDISH

559 total citations
16 papers, 479 citations indexed

About

D. E. BRUNDISH is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmaceutical Science. According to data from OpenAlex, D. E. BRUNDISH has authored 16 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Cellular and Molecular Neuroscience and 5 papers in Pharmaceutical Science. Recurrent topics in D. E. BRUNDISH's work include Chemical Synthesis and Analysis (7 papers), Chemical Reactions and Isotopes (5 papers) and Amino Acid Enzymes and Metabolism (2 papers). D. E. BRUNDISH is often cited by papers focused on Chemical Synthesis and Analysis (7 papers), Chemical Reactions and Isotopes (5 papers) and Amino Acid Enzymes and Metabolism (2 papers). D. E. BRUNDISH collaborates with scholars based in Switzerland, United Kingdom and United States. D. E. BRUNDISH's co-authors include Rebecca C. Wade, B.E.B. Sandberg, Michael R. Hanley, Leslie L. Iversen, William E. Fogler, Isaiah J. Fidler, H. Bittiger, Roland Heckendorn, Hans Allgeier and M. Steinmann and has published in prestigious journals such as Nature, Journal of Neuroscience and The Journal of Immunology.

In The Last Decade

D. E. BRUNDISH

16 papers receiving 457 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. E. BRUNDISH Switzerland 9 315 295 49 47 47 16 479
Victoria Moncada United States 13 269 0.9× 305 1.0× 38 0.8× 55 1.2× 43 0.9× 15 594
Hyeon Joo Yim United States 12 309 1.0× 274 0.9× 51 1.0× 64 1.4× 24 0.5× 14 539
Jean Ménager France 15 366 1.2× 426 1.4× 78 1.6× 30 0.6× 30 0.6× 20 616
Moshe Gavish Israel 10 193 0.6× 164 0.6× 35 0.7× 38 0.8× 34 0.7× 14 355
Mary H. Richards France 13 289 0.9× 344 1.2× 33 0.7× 26 0.6× 22 0.5× 24 488
K Ohno Japan 11 208 0.7× 199 0.7× 40 0.8× 17 0.4× 45 1.0× 26 402
Albert Braunwalder Switzerland 15 504 1.6× 600 2.0× 63 1.3× 47 1.0× 136 2.9× 31 942
M.S. Levine United States 11 228 0.7× 201 0.7× 83 1.7× 73 1.6× 18 0.4× 16 511
J F Dixon United States 14 135 0.4× 379 1.3× 64 1.3× 19 0.4× 15 0.3× 16 655
Dieter Seidelmann Denmark 6 190 0.6× 189 0.6× 31 0.6× 87 1.9× 100 2.1× 10 499

Countries citing papers authored by D. E. BRUNDISH

Since Specialization
Citations

This map shows the geographic impact of D. E. BRUNDISH's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. E. BRUNDISH with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. E. BRUNDISH more than expected).

Fields of papers citing papers by D. E. BRUNDISH

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. E. BRUNDISH. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. E. BRUNDISH. The network helps show where D. E. BRUNDISH may publish in the future.

Co-authorship network of co-authors of D. E. BRUNDISH

This figure shows the co-authorship network connecting the top 25 collaborators of D. E. BRUNDISH. A scholar is included among the top collaborators of D. E. BRUNDISH based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. E. BRUNDISH. D. E. BRUNDISH is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Fagg, Graham E., H.‐R. Olpe, M.F. Pozza, et al.. (1990). CGP 37849 and CGP 39551: novel and potent competitive N‐methyl‐d‐aspartate receptor antagonists with oral activity. British Journal of Pharmacology. 99(4). 791–797. 174 indexed citations
2.
Schmutz, Markus, et al.. (1990). CGP 37849 and CGP 39551: novel competitive N-methyl-D-aspartate receptor antagonists with potent oral anticonvulsant activity.. PubMed. 361. 421–7. 7 indexed citations
3.
BRUNDISH, D. E. & Rebecca C. Wade. (1986). Tritiated peptides. Part 161. Synthesis of [3H‐Tyr8]‐physalaemin. Journal of Labelled Compounds and Radiopharmaceuticals. 23(1). 9–19. 1 indexed citations
4.
Weightman, D. R., et al.. (1985). Rat brain membranes possess two high-affinity binding sites for [3H]somatostatin. Neuroscience Letters. 55(2). 161–166. 37 indexed citations
5.
Bahouth, Suleiman W., et al.. (1985). Specific binding of [3H-Tyr8]physalaemin to rat submaxillary gland substance P receptor.. Molecular Pharmacology. 27(1). 38–45. 12 indexed citations
6.
Fogler, William E., et al.. (1985). Distribution and fate of free and liposome-encapsulated [3H]nor-muramyl dipeptide and [3H]muramyl tripeptide phosphatidylethanolamine in mice.. The Journal of Immunology. 135(2). 1372–1377. 59 indexed citations
7.
BRUNDISH, D. E. & Rebecca C. Wade. (1985). Synthesis of N‐[2‐3H] acetyl‐D‐muramyl‐L‐alanyl‐D‐iso‐glutaminyl‐L‐alanyl‐2‐(1′,2′‐dipalmitoyl ‐sn‐glycero‐3′‐phosphoryl) ethylamide of high specific radioactivity. Journal of Labelled Compounds and Radiopharmaceuticals. 22(1). 29–35. 1 indexed citations
8.
BRUNDISH, D. E., et al.. (1985). Specific labeling of rat brain substance P receptor with [3H]physalaemin. Journal of Neuroscience. 5(8). 2078–2085. 25 indexed citations
9.
BRUNDISH, D. E.. (1985). synthesis of 10‐[3H]‐5H‐dibenz[b, f] azepine‐5‐carboxamide ([3H]‐carbamazepine). Journal of Labelled Compounds and Radiopharmaceuticals. 22(1). 37–41. 2 indexed citations
10.
Baschang, Gerhard, D. E. BRUNDISH, A. A. Hartmann, J. Staněk, & Rebecca C. Wade. (1983). The synthesis of N‐[3H] acetyl muramyl dipeptides of high specific radioactivity. Journal of Labelled Compounds and Radiopharmaceuticals. 20(6). 691–696. 4 indexed citations
11.
Sandberg, B.E.B., Michael R. Hanley, Steve P. Watson, et al.. (1982). Synthesis and metabolic stability of a tritium‐labelled substance P analogue. FEBS Letters. 137(2). 236–240. 10 indexed citations
12.
Märki, F., L. Schenkel, Andrew J. Czernik, et al.. (1981). Rapid conversion of somatostatin to active metabolite in human plasma. FEBS Letters. 127(1). 22–24. 10 indexed citations
13.
Hanley, Michael R., et al.. (1980). Specific binding of 3H-substance P to rat brain membranes. Nature. 286(5775). 810–812. 115 indexed citations
14.
BRUNDISH, D. E. & Rebecca C. Wade. (1977). The synthesis of tritium-labelled human corticotropin of high specific radioactivity. Biochemical Journal. 165(1). 169–171. 5 indexed citations
15.
BRUNDISH, D. E. & Ruth S. Wade. (1972). The synthesis of β-corticotrophin-(1-24)-tetracosapeptide (synacthen) of high specific radioactivity. Biochemical Journal. 129(2). 23P–23P. 3 indexed citations
16.
BRUNDISH, D. E., D. F. Elliott, & Roy Wade. (1971). The synthesis of l‐amino acids and their derivatives labelled with 3H. Journal of Labelled Compounds. 7(4). 473–493. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026